Viking Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC VKTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

238,227

Value ($000)

8,381

Weight

0.0%

2019 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	8,381	0.0%	238,227	12/31/2025
2025 Q3	11/14/2025	6,406	0.0%	243,766	9/30/2025
2025 Q2	8/14/2025	13,491	0.0%	509,094	6/30/2025
2025 Q1	5/19/2025	11,351	0.0%	470,028	3/31/2025
2024 Q4	2/14/2025	18,644	0.0%	463,332	12/31/2024
2024 Q3	11/14/2024	29,898	0.0%	472,244	9/30/2024
2024 Q2	8/14/2024	25,413	0.0%	479,394	6/30/2024
2024 Q1	5/15/2024	29,158	0.0%	355,588	3/31/2024
2023 Q4	2/14/2024	8,842	0.0%	475,113	12/31/2023
2023 Q3	11/13/2023	5,299	0.0%	478,695	9/30/2023
2022 Q1	5/16/2022	333	0.0%	111,159	3/31/2022
2021 Q4	2/14/2022	511	0.0%	111,159	12/31/2021
2021 Q3	11/15/2021	698	0.0%	111,159	9/30/2021
2021 Q2	8/16/2021	774	0.0%	129,228	6/30/2021
2021 Q1	5/14/2021	634	0.0%	100,240	3/31/2021
2020 Q4	3/1/2021	724	0.0%	128,640	12/31/2020
2020 Q3	11/13/2020	420	0.0%	72,140	9/30/2020
2020 Q2	8/14/2020	520	0.0%	72,140	6/30/2020
2020 Q1	5/15/2020	406	0.0%	86,663	3/31/2020
2019 Q4	2/14/2020	702	0.0%	87,524	12/31/2019